Analysis reveals key outcomes and challenges of digital technologies in the pharmaceutical industry in both nations, suggesting opportunities for Russia.
The article analyzes the main global trends and challenges of the ongoing digital transformation in modern pharmaceutical industry. The author highlights the specific approaches and key achievements in the development of the digital pharmaceutical sector in the United States and China, including their positions in the global market for digital technologies, the main components and outcomes of their national strategies for digital transformation, and projects based on Industry 4.0 and Pharma 4.0 concepts and their results. The prospects for digital transformation in Russia's pharmaceutical industry in the context of new challenges are also assessed.
No takes yet. Share an insight, caveat, or question.
Valentina Dorzhieva (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: